WE ARE
Skin diseases impact a patient’s life in more ways than the itch, rash, and dry skin often associated with these conditions. For those affected, the impact of skin disease often comes with mental health issues such as anxiety, social isolation, depression, and a lower quality of life. Currently available treatments for inflammatory skin diseases typically have limited efficacy or strong side effects that severely reduce patient compliance.
Derm-Biome Pharmaceuticals, Inc. is a Vancouver-based preclinical biopharmaceutical company founded in 2018. We are focused on developing and advancing safe and highly effective topical therapies for inflammatory skin diseases, precancerous skin conditions, and non-melanoma skin cancers, each of which represents a significant unmet need.
In the News
Timeline
Who we’re working with
Acne / Rosacea
Atopic Dermatitis
Pre-Cancer / Skin Cancer
Anti-Aging / Skin Aging
About Us
Our Purpose
Our Team
Investor Inquiries:
Gordon Eberwein
geberwein@derm-biome.com
derm-biomepharmaceuticals.com